In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...
Modified Toxicity Probability Interval Design: A Safer and More Reliable Method Than the 3 + 3 Design for Practical Phase I Trials. If you have the appropriate software installed, you can download ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results